Clinical Trial Update: SPI-1005 in Adults Receiving Cochlear Implant [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SPI-1005 in adults receiving cochlear implants; trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cochlear Trauma
• Hearing Loss

Drugs mentioned

• SPI-1005

Snippet

Sponsor: Sound Pharmaceuticals, Incorporated | Conditions: Hearing Loss, Cochlear Trauma | Phase 2 | Status: RECRUITING